has necessitated the restandardization of IQ tests every decade or so; however , in India many IQ tests have not been standardized for use at all, or have been standardized so long ago that the norms are probably obsolete (Andrade and Jamuna, 2004) . The situation is both deplorable and indefensible, which is why we are surprised that Dr . Sarkar considers our call for large-scale changes in assessment tools and standards "premature and erroneous". Dr . Sarkar correctly notes that the Flynn effect has not been demonstrated in India. However , this is so only because nobody has so far looked for it. In effect, the situation is an indictment of Indian researchers in the field, and not an indictment of the applicability of the concept in a third world country, because absence of evidence is not evidence of absence. In further refutation of the ar gument of Dr. Sarkar is the demonstration of the Flynn effect in as many as 20 countries across the world (Flynn, 1999); does Dr. Sarkar consider that these 20 countries exhibit no diversity in "child rearing practices, parental intelligence, environmental stimulation available to infants, formal and informal learning opportunities, and dietary and economic realities"? Ergo, there is no logical reason why India should prove to be an exception to a geographically sweeping trend. Good clinicians err on the side of caution. Therefore, if at all there is a burden of proof required, it would be for researchers to show that the Flynn effect does NOT exist in this country. Until such a time, let us standardize our tests, update our norms, and move on.
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Clozapine Induced Urinary Incontinence During Sleep
Sir, One of the common side effects of clozapine is sedation, especially early in the course of treatment. Due to this, most of the clozapine dosage may be administered at night. This results in many patients reporting urinary incontinence during sleep when they are put on clozapine. This embarrassing and distressing side effect of clozapine may lead to noncompliance in some patients. The reported prevalence of this side effect varies from as low as 0.23% (Lieberman et al, 1989) to as high as 44% (Lin et al, 1999) . In order to estimate the frequency of this side effect in our hospital set-up, 100 consecutive patients of schizophrenia or bipolar mood disorder , receiving clozapine were interviewed and specifically asked about urinary incontinence during sleep.
Out of these 100 patients, 15 patients reported having this side effect. Though one patient reported this side effect at a dose of only 50 mg/day , majority of them were receiving 100 mg or more of clozapine when they experienced urinary incontinence during sleep. As expected, this side effect was observed either in first 2-3 weeks of initiation of treatment or when the dose was increased subsequently . In 3 patients incontinence occurred only once or twice and stopped by itself without any dose adjustment. While in other 9 patients dose reduction was required. In other 3 patients in whom the dose reduction was not considered desirable, the incontinence stopped after they were started on 25 mg of imipramine at bedtime.
